Clinical relevance of Chlamydia pneumoniae infections - From the respiratory tract to the vascular system;Klinische relevanz der Chlamydia pneumoniae infektion - Vom respirationstrakt bis zum gefasssystem

Pneumologie

Volumn 54, Issue 11, 2000, Pages 517-524

  Dalhoff, K ^a   Kothe, H ^a   Maass, M ^b   Katus, H A ^a  

^a UNIVERSITY OF LÜBECK   (Germany)

^b Inst für Med Mikrobiologie   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; DOXYCYCLINE; ERYTHROMYCIN; LEVOFLOXACIN; MOXIFLOXACIN; OFLOXACIN; PENICILLIN G; RIFAMPICIN; ROXITHROMYCIN;

ASTHMA; BACTERIAL INFECTION; CARDIOVASCULAR SYSTEM; CHLAMYDOPHILA PNEUMONIAE; CLINICAL FEATURE; HUMAN; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY SYSTEM; REVIEW; SEROPREVALENCE;

CARDIOVASCULAR DISEASES; CHLAMYDIA INFECTIONS; CHLAMYDOPHILA PNEUMONIAE; HUMANS; PNEUMONIA, BACTERIAL; RESPIRATORY TRACT INFECTIONS;

EID: 0033668879     PISSN: 09348387     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2000-8251     Document Type: Review

References (62)

1. Chlamydial infections of the respiratory tract
2. Chlamydia pneumoniae, Strain TWAR
3. Replication of Chlamydia pneumoniae in vitro in human macrophages, endothelial cells and aortic artery smooth muscle cells
4. Multiple sclerosis associated with Chlamydia pneumoniae infection of the CNS
5. A new respiratory tract pathogen: Chlamydia pneumoniae Strain TWAR
6. Epidemics of pneumonia caused by TWAR, a new Chlamydia organism, in military trainees in Finland
7. Asymptomatic respiratory tract infection with Chlamydia pneumoniae TWAR
8. Incidence of commmunity-acquired pneumonia and Chlamydia pneumoniae infection: A prospective multicentre study
9. New and emerging etiologies fur community-acquired pneumonia with implications for therapy
10. Incidence of community-acquired pneumonia requiring hospitalization: Results of a population-based surveillance study in Ohio
11. Chlamydia pneumoniae as a cause of community acquired pneumonia in hospitalized patients in Berlin
12. Community-acquired pneumonia guidelines - An international comparison
13. Roentgenographic findings of pneumonia caused by Chlamydia pneumoniae
14. Chlamydia pneumoniae as a new source of infectious outbreaks in nursing homes
15. Persistent infection with Chlamydia pneumoniae following acute respiratory illness
16. Chlamydia pneumoniae, a new causative agent of reactive arthritis and undifferentiated oligoarthritis
17. Lofgren's syndrome as the first manifestation of acute infection due to Chlamydia pneumoniae: A prospective study
18. Growth of Chlamydia pneumoniae induces cytokine production and expression of CD 14 in a human monocytic cell line
19. Signal transduction pathways activated in endothelial cells following infection with Chlamydia pneumoniae
20. Interaction of Chlamydia pneumoniae and human alveolar macrophages: Infection and inflammatory response
21. Reactivation of Chlamydia pneumoniae lung infection in mice by cortisone
22. Isolation of Chlamydia pneumoniae from the lungs of patients infected with the human immunodeficiency virus
23. Chlamydia pneumoniae seroprevalence in immunocompetent and immunocompromised populations in Milan
24. Chlamydia pneumoniae pneumonia in hospitalized patients
25. Microbiologic efficacy of azithromycin and susceptibility to azithromycin of isolates of Chlamydia pneumoniae from adults and children with community-acquired pneumonia
26. Guidelines for the initial management of adults with community-acquired pneumonia: Diagnosis, assessment of severity, and initial antmicrobial therapy
27. Community-acquired pneumonia in adults: Guidelines for management
28. Association of Chlamydia pneumoniae (Strain TWAR) infection with wheezing, asthmatic bronchitis and adult-onset asthma
29. Chlamydia pneumoniae-induced ciliostasis in ciliated bronchial epithelial cells
30. Detection of anti-Chlamydia pneumoniae IgE in children with reactive airway disease
31. Chlamydia pneumoniae and asthma
32. Chronic Chlamydia pneumoniae infection and asthma exacerbations in children
33. Can acute Chlamydia pneumoniae respiratory tract infection initiate chronic asthma?
34. Asthma, atopy and Chlamydia pneumoniae antibodies in adults
35. Detection of viral, Chlamydia pneumoniae and Mycoplasma pneumoniae infections in exacerbations of asthma in children
36. Chlamydia pneumoniae and exacerbations of asthma in adults
37. Chlamydia pneumoniae asthma roxithromycin multinational study (CARM)
38. Chlamydia pneumoniae, Strain TWAR, infection in patients with chronic obstructive pulmonary disease
39. Chlamydia pneumoniae infection in patients with diffuse panbronchiolitis and COPD
40. Acute purulent exacerbation of chronic obstructive pulmonary disease and Chlamydia pneunomiae infection
41. The role of chlamydia in the pathogenesis of pulmonary emphysema. Electron microscopy and immunofluorescence reveal corresponding findings as in atherosclerosis
42. Acute respiratory-tract infection and risk of first-time acute myocardial infarction
43. Serological evidence of an association of a novel Chlamydia, TWAR, with chronic heart disease and acute myocardial infarction
44. Chronic infections and coronary heart disease: Is there a link?
45. Prominent serological response to Chlamydia pneumoniae in cardiovascular disease
46. Endovascular presence of viable Chlamydia pneumoniae is a common phenomenon in coronary artery disease
47. Detection of Chlamydia pneumoniae TWAR in human coronary atherectomy tissues
48. Isolation of Chlamydia pneumoniae from the coronary artery of a patient with coronary atherosclerosis
49. Evidence of systemic dissemination of Chlamydia pneumoniae via macrophages in the mouse
50. Detection of Chlamydia pneumoniae within peripheral blood monocytes of patients with unstable angina or myocardial infarction
51. Monocyte-endothelial cell coculture enhances infection of endothelial cells with Chlamydia pneumoniae
52. Hydroxymethylglutaryl coenzyme a reductase inhibitors modify the inflammatory response of human macrophages and endothelial cells infected with Chlamydia pneumoniae
53. Chlamydia pneumoniae infection induces inflammatory changes in the aorta of rabbits
54. Randomised trial of roxithromycin in non-Q-wave coronary syndromes: Roxis pilot study
55. Elevated Chlamydia pneumoniae antibodies, cardiovascular events and azithromycin in male survivors of myocardial infarction
56. Randomized secondary prevention trial of azithromycin in patients with coronary artery disease and serological evidence for Chlamydia pneumoniae infection. The Azithromycin in Coronary Artery Disease Elimination of Myocardial Infection with Chlamydia (ACADEMIC) study
57. Clinical and immunoregulatory effects of roxithromycin therapy for chronic respiratory tract infection
58. Roxithromycin reduces the degree of bronchial hyperresponsiveness in children with asthma
59. Pravastatin sodium activates endothelial nitric oxide synthase independent of ist cholesterol lowering action
60. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels
61. In vitro susceptibility of Chlamydia pneumoniae strains recovered from atherosclerotic coronary arteries